Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Highly efficient NRF2 activators-co-releasing molecule hybrids, their use in the treatment of inflammatory or cardiovascular diseases and their process of preparation

Highly efficient NRF2 activators-co-releasing molecule hybrids, their use in the treatment of inflammatory or cardiovascular diseases and their process of preparation

US Patent 10519179 · Granted Dec 31, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method and apparatus for bag throwing game2025
Throwing game board2020
Derivatives of oxazaphosphorines that are pre-activated, use and method of prepa2018
Derivatives of oxazaphosphorines that are pre-activated, use and method of prepa2018
Derivatives of oxazaphosphorines and therapeutic uses thereof2018
Derivatives of oxazaphosphorines and therapeutic uses thereof2018
Fumarate-CO-releasing molecule hybrids, their use in the treatment of inflammato2018
Fumarate-CO-releasing molecule hybrids, their use in the treatment of inflammato2018
Fumarate-CO-releasing molecule hybrids, their use in the treatment of inflammato2018
Fumarate-CO-releasing molecule hybrids, their use in the treatment of inflammato2018
Chemical model of a neurodegenerative disease, method for preparation and uses o2017
Chemical model of a neurodegenerative disease, method for preparation and uses o2017